Download PDF
Digestive Disease Interventions 2019; 03(03): 203-213
DOI: 10.1055/s-0039-1693414
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Pediatric Lymphangiography: Imaging to Intervention

Shimwoo Lee
1   Department of Radiology, Division of Vascular and Interventional Radiology, UCLA Medical Center, Los Angeles, California
,
Aarti P. Luhar
1   Department of Radiology, Division of Vascular and Interventional Radiology, UCLA Medical Center, Los Angeles, California
,
Edward Wolfgang Lee
1   Department of Radiology, Division of Vascular and Interventional Radiology, UCLA Medical Center, Los Angeles, California
,
Sanjay Sinha
2   Department of Medicine, Division of Cardiovascular Disease, UCLA Medical Center, Los Angeles, California
,
Ravi N. Srinivasa
1   Department of Radiology, Division of Vascular and Interventional Radiology, UCLA Medical Center, Los Angeles, California
› Author Affiliations
Further Information

Publication History

06 March 2019

15 May 2019

Publication Date:
22 August 2019 (online)

Also available at
    Permissions and Reprints

Abstract

The lymphatic system plays a crucial role in fluid transport as well as facilitating immune recognition. Disruption of lymphatic flow can lead to significant morbidity and mortality in the pediatric population, manifesting as lymphatic malformations and lymphatic leaks. There has been rising interest in developing minimally invasive image-guided approaches to diagnose and treat lymphatic disorders in pediatric patients. Notably, magnetic resonance imaging of the lymphatic system has emerged as a promising diagnostic tool. Moreover, interventions such as sclerotherapy and thoracic duct embolization for treatment of lymphatic malformations and leaks have come forth as safe and effective alternatives to surgery. The aim of this article is to review various pediatric lymphatic disorders and discuss advances in image-guided diagnostic and therapeutic options for these entities.

Keywords

lymphangiography - pediatrics - embolization - lymphatic malformation

Disclosure

The authors have no relevant disclosures.


All authors have read and contributed to this manuscript.


 

  • References

  • 1 Cope C, Salem R, Kaiser LR. Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial. J Vasc Interv Radiol 1999; 10 (09) 1248-1254
    CrossrefPubMedGoogle Scholar
  • 2 Cope C, Kaiser LR. Management of unremitting chylothorax by percutaneous embolization and blockage of retroperitoneal lymphatic vessels in 42 patients. J Vasc Interv Radiol 2002; 13 (11) 1139-1148
    CrossrefPubMedGoogle Scholar
  • 3 Nadolski GJ, Itkin M. Feasibility of ultrasound-guided intranodal lymphangiogram for thoracic duct embolization. J Vasc Interv Radiol 2012; 23 (05) 613-616
    CrossrefPubMedGoogle Scholar
  • 4 Rajebi MR, Chaudry G, Padua HM. , et al. Intranodal lymphangiography: feasibility and preliminary experience in children. J Vasc Interv Radiol 2011; 22 (09) 1300-1305
    CrossrefPubMedGoogle Scholar
  • 5 Johnson OW, Chick JFB, Chauhan NR. , et al. The thoracic duct: clinical importance, anatomic variation, imaging, and embolization. Eur Radiol 2016; 26 (08) 2482-2493
    CrossrefPubMedGoogle Scholar
  • 6 Chavhan GB, Amaral JG, Temple M, Itkin M. MR lymphangiography in children: technique and potential applications. Radiographics 2017; 37 (06) 1775-1790
    CrossrefPubMedGoogle Scholar
  • 7 Bhardwaj R, Vaziri H, Karimeddini D, Gautam A, Ballesteros E, Wu GY. Chylous ascites: a review of pathogenesis, diagnosis and treatment. J Clin Transl J Clin Transl Hepatol 2018; 6 (01) 105-113
    CrossrefPubMedGoogle Scholar
  • 8 Temple M, Krishnamurthy G. Vascular interventions: lymphangiography and thoracic duct embolizations. In: Temple M, Marshalleck FE. , eds. pediatric interventional radiology: handbook of vascular and non-vascular interventions. New York, NY: Springer; 2014: 251-261
    Google Scholar
  • 9 Chen E, Itkin M. Thoracic duct embolization for chylous leaks. Semin Intervent Radiol 2011; 28 (01) 63-74
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Feldt RH, Driscoll DJ, Offord KP. , et al. Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg 1996; 112 (03) 672-680
    CrossrefPubMedGoogle Scholar
  • 11 Kennedy TL, Whitaker M, Pellitteri P, Wood WE. Cystic hygroma/lymphangioma: a rational approach to management. Laryngoscope 2001; 111 (11 Pt 1): 1929-1937
    CrossrefPubMedGoogle Scholar
  • 12 Dubois J, Garel L, Abela A, Laberge L, Yazbeck S. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology 1997; 204 (03) 651-654
    CrossrefPubMedGoogle Scholar
  • 13 Defnet AM, Bagrodia N, Hernandez SL, Gwilliam N, Kandel JJ. Pediatric lymphatic malformations: evolving understanding and therapeutic options. Pediatr Surg Int 2016; 32 (05) 425-433
    CrossrefPubMedGoogle Scholar
  • 14 Alqahtani A, Nguyen LT, Flageole H, Shaw K, Laberge JM. 25 years' experience with lymphangiomas in children. J Pediatr Surg 1999; 34 (07) 1164-1168
    CrossrefPubMedGoogle Scholar
  • 15 Schoinohoriti OK, Theologie-Lygidakis N, Tzerbos F, Iatrou I. Lymphatic malformations in children and adolescents. J Craniofac Surg 2012; 23 (06) 1744-1747
    CrossrefPubMedGoogle Scholar
  • 16 Francavilla ML, White CL, Lee EY, Oliveri B, Restrepo R. Intraabdominal Lymphatic Malformations: Pearls and Pitfalls of Diagnosis and Differential Diagnoses in Pediatric Patients. AJR Am J Roentgenol 2017; 208 (3): 637-649
    CrossrefPubMedGoogle Scholar
  • 17 Brouillard P, Boon L, Vikkula M. Genetics of lymphatic anomalies. J Clin Invest 2014; 124 (03) 898-904
    CrossrefPubMedGoogle Scholar
  • 18 Connell FC, Ostergaard P, Carver C. , et al; Lymphoedema Consortium. Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas. Hum Genet 2009; 124 (06) 625-631
    CrossrefPubMedGoogle Scholar
  • 19 Mäkinen T, Veikkola T, Mustjoki S. , et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 2001; 20 (17) 4762-4773
    CrossrefPubMedGoogle Scholar
  • 20 Acord M, Srinivasan AS, Cahill AM. Percutaneous treatment of lymphatic malformations. Tech Vasc Interv Radiol 2016; 19 (04) 305-311
    CrossrefPubMedGoogle Scholar
  • 21 Strychowsky JE, Rahbar R, O'Hare MJ, Irace AL, Padua H, Trenor III CC. Sirolimus as treatment for 19 patients with refractory cervicofacial lymphatic malformation. Laryngoscope 2018; 128 (01) 269-276
    CrossrefPubMedGoogle Scholar
  • 22 García-Montero P, Del Boz J, Sanchez-Martínez M, Escudero Santos IM, Baselga E. Microcystic lymphatic malformation successfully treated with topical rapamycin. Pediatrics 2017; 139 (05) e20162105 . Doi: 10.1542/peds.2016-2105
    CrossrefPubMedGoogle Scholar
  • 23 Ivars M, Redondo P. Efficacy of topical sirolimus (Rapamycin) for the treatment of microcystic lymphatic malformations. JAMA Dermatol 2017; 153 (01) 103-105
    CrossrefPubMedGoogle Scholar
  • 24 Okazaki T, Iwatani S, Yanai T. , et al. Treatment of lymphangioma in children: our experience of 128 cases. J Pediatr Surg 2007; 42 (02) 386-389
    CrossrefPubMedGoogle Scholar
  • 25 Balakrishnan K, Menezes MD, Chen BS, Magit AE, Perkins JA. Primary surgery vs primary sclerotherapy for head and neck lymphatic malformations. JAMA Otolaryngol Head Neck Surg 2014; 140 (01) 41-45
    CrossrefPubMedGoogle Scholar
  • 26 Shergill A, John P, Amaral JG. Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy. Pediatr Radiol 2012; 42 (09) 1080-1088
    CrossrefPubMedGoogle Scholar
  • 27 Alomari AI, Karian VE, Lord DJ, Padua HM, Burrows PE. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol 2006; 17 (10) 1639-1648
    CrossrefPubMedGoogle Scholar
  • 28 Thottam PJ, Al-Barazi R, Madgy DN, Rozzelle A. Submucosal resection of a microcystic oropharyngeal lymphatic malformation using radiofrequency ablation. Int J Pediatr Otorhinolaryngol 2013; 77 (09) 1589-1592
    CrossrefPubMedGoogle Scholar
  • 29 Colbert SD, Seager L, Haider F, Evans BT, Anand R, Brennan PA. Lymphatic malformations of the head and neck-current concepts in management. Br J Oral Maxillofac Surg 2013; 51 (02) 98-102
    CrossrefPubMedGoogle Scholar
  • 30 Shaikh R. Percutaneous image-guided cryoablation in vascular anomalies. Semin Intervent Radiol 2017; 34 (03) 280-287
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Tutor JD. Chylothorax in infants and children. Pediatrics 2014; 133 (04) 722-733
    CrossrefPubMedGoogle Scholar
  • 32 Chan EH, Russell JL, Williams WG, Van Arsdell GS, Coles JG, McCrindle BW. Postoperative chylothorax after cardiothoracic surgery in children. Ann Thorac Surg 2005; 80 (05) 1864-1870
    CrossrefPubMedGoogle Scholar
  • 33 Chan S yan, Lau W, Wong WHS, Cheng L cheung, Chau AKT, Cheung Y fai. Chylothorax in Children After Congenital Heart Surgery. Ann Thorac Surg 2006; 82 (05) 1650-1656
    CrossrefPubMedGoogle Scholar
  • 34 Campagna J, Jain R. Thoracic duct embolization. In: Kessel D, Ray C. eds. Transcatheter embolization and therapy. London: Springer; 2010: 471-472
    CrossrefGoogle Scholar
  • 35 Maldonado F, Cartin-Ceba R, Hawkins FJ, Ryu JH. Medical and surgical management of chylothorax and associated outcomes. Am J Med Sci 2010; 339 (04) 314-318
    CrossrefPubMedGoogle Scholar
  • 36 Krishnamurthy R, Hernandez A, Kavuk S, Annam A, Pimpalwar S. Dynamic magnetic resonance lymphangiography (MRL): A new technique to image the central conducting lymphatics (CCL). J Vasc Interv Radiol 2013; 24 (04) S28
    PubMedGoogle Scholar
  • 37 Pamarthi V, Pabon-Ramos WM, Marnell V, Hurwitz LM. MRI of the central lymphatic system: indications, imaging technique, and pre-procedural planning. Top Magn Reson Imaging 2017; 26 (04) 175-180
    CrossrefPubMedGoogle Scholar
  • 38 Nadolski GJ, Ponce-Dorrego MD, Darge K, Biko DM, Itkin M. Validation of the position of injection needles with contrast-enhanced ultrasound for dynamic contract-enhanced MR lymphangiography. J Vasc Interv Radiol 2018; 29 (07) 1028-1030
    CrossrefPubMedGoogle Scholar
  • 39 Kawasaki R, Sugimoto K, Fujii M. , et al. Therapeutic effectiveness of diagnostic lymphangiography for refractory postoperative chylothorax and chylous ascites: correlation with radiologic findings and preceding medical treatment. AJR Am J Roentgenol 2013; 201 (03) 659-666
    CrossrefPubMedGoogle Scholar
  • 40 Matsumoto T, Yamagami T, Kato T. , et al. The effectiveness of lymphangiography as a treatment method for various chyle leakages. Br J Radiol 2009; 82 (976) 286-290
    CrossrefPubMedGoogle Scholar
  • 41 Yamagami T, Masunami T, Kato T. , et al. Spontaneous healing of chyle leakage after lymphangiography. Br J Radiol 2005; 78 (933) 854-857
    CrossrefPubMedGoogle Scholar
  • 42 Gray M, Kovatis KZ, Stuart T. , et al. Treatment of congenital pulmonary lymphangiectasia using ethiodized oil lymphangiography. J Perinatol 2014; 34 (09) 720-722
    CrossrefPubMedGoogle Scholar
  • 43 Gough MH. Lymphangiography in children. Arch Dis Child 1964; 39: 177-181
    CrossrefPubMedGoogle Scholar
  • 44 Itkin M, Krishnamurthy G, Naim MY, Bird GL, Keller MS. Percutaneous thoracic duct embolization as a treatment for intrathoracic chyle leaks in infants. Pediatrics 2011; 128 (01) e237-e241
    CrossrefPubMedGoogle Scholar
  • 45 Nair SK, Petko M, Hayward MP. Aetiology and management of chylothorax in adults. Eur J Cardiothorac Surg 2007; 32 (02) 362-369
    CrossrefPubMedGoogle Scholar
  • 46 Berzigotti A, Magalotti D, Cocci C, Angeloni L, Pironi L, Zoli M. Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report. Dig Liver Dis 2006; 38 (02) 138-142
    PubMedGoogle Scholar
  • 47 Ferguson MK, Little AG, Skinner DB. Current concepts in the management of postoperative chylothorax. Ann Thorac Surg 1985; 40 (06) 542-545
    CrossrefPubMedGoogle Scholar
  • 48 Nath DS, Savla J, Khemani RG, Nussbaum DP, Greene CL, Wells WJ. Thoracic duct ligation for persistent chylothorax after pediatric cardiothoracic surgery. Ann Thorac Surg 2009; 88 (01) 246-251
    CrossrefPubMedGoogle Scholar
  • 49 Cope C. Management of chylothorax via percutaneous embolization. Curr Opin Pulm Med 2004; 10 (04) 311-314
    CrossrefPubMedGoogle Scholar
  • 50 McGrath EE, Blades Z, Anderson PB. Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med 2010; 104 (01) 1-8
    CrossrefPubMedGoogle Scholar
  • 51 Binkert CA, Yucel EK, Davison BD, Sugarbaker DJ, Baum RA. Percutaneous treatment of high-output chylothorax with embolization or needle disruption technique. J Vasc Interv Radiol 2005; 16 (09) 1257-1262
    CrossrefPubMedGoogle Scholar
  • 52 Litherland B, Given M, Lyon S. Percutaneous radiological management of high-output chylothorax with CT-guided needle disruption. J Med Imaging Radiat Oncol 2008; 52 (02) 164-167
    CrossrefPubMedGoogle Scholar
  • 53 Pamarthi V, Stecker MS, Schenker MP. , et al. Thoracic duct embolization and disruption for treatment of chylous effusions: experience with 105 patients. J Vasc Interv Radiol 2014; 25 (09) 1398-1404
    CrossrefPubMedGoogle Scholar
  • 54 Itkin M, Kucharczuk JC, Kwak A, Trerotola SO, Kaiser LR. Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J Thorac Cardiovasc Surg 2010; 139 (03) 584-589
    CrossrefPubMedGoogle Scholar
  • 55 Majdalany BS, Saad WA, Chick JFB, Khaja MS, Cooper KJ, Srinivasa RN. Pediatric lymphangiography, thoracic duct embolization and thoracic duct disruption: a single-institution experience in 11 children with chylothorax. Pediatr Radiol 2018; 48 (02) 235-240
    CrossrefPubMedGoogle Scholar
  • 56 Chung A, Gill AE, Rahman FN, Hawkins CM. Retrograde thoracic duct embolization in a pediatric patient with total cavopulmonary connection and plastic bronchitis. J Vasc Interv Radiol 2015; 26 (11) 1743-1746
    CrossrefPubMedGoogle Scholar
  • 57 Kim J, Won JH. Percutaneous treatment of chylous ascites. Tech Vasc Interv Radiol 2016; 19 (04) 291-298
    CrossrefPubMedGoogle Scholar
  • 58 Lee EW, Shin JH, Ko HK, Park J, Kim SH, Sung KB. Lymphangiography to treat postoperative lymphatic leakage: a technical review. Korean J Radiol 2014; 15 (06) 724-732
    CrossrefPubMedGoogle Scholar
  • 59 Itkin M, Piccoli DA, Nadolski G. , et al. Protein-Losing Enteropathy in Patients With Congenital Heart Disease. J Am Coll Cardiol 2017; 69 (24) 2929-2937
    CrossrefPubMedGoogle Scholar
  • 60 Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group. J Thorac Cardiovasc Surg 1998; 115 (05) 1063-1073
    CrossrefPubMedGoogle Scholar
  • 61 Copland A, DiBaise J. Protein losing enteropathy: diagnosis and management. Pract Gastroenterol 2017; 162: 22-35
    PubMedGoogle Scholar
  • 62 Levitt DG, Levitt MD. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med 2016; 9: 229-255
    CrossrefPubMedGoogle Scholar
  • 63 Udink Ten Cate FE, Hannes T, Germund I. , et al. Towards a proposal for a universal diagnostic definition of protein-losing enteropathy in Fontan patients: a systematic review. Heart 2016; 102 (14) 1115-1119
    CrossrefPubMedGoogle Scholar
  • 64 Umar SB, DiBaise JK. Protein-losing enteropathy: case illustrations and clinical review. Am J Gastroenterol 2010; 105 (01) 43-49 , quiz 50
    CrossrefPubMedGoogle Scholar